GSK announced a five-year collaboration with The Jackson Laboratory and NYSCF to develop human cellular models for neurodegenerative disease drug discovery.
Longevity News
Pharma giant GSK is launching a five-year collaboration with The Jackson Laboratory–New York Stem Cell Foundation to...
Source: FierceBiotech - All • Published: 18 Feb 2026, 22:00
Continue exploring
Related longevity signals
Frontiers - HealthHematopoietic Stem Cell Transplantation for DOCK8 Deficiency: Durable Immune Reconstitution and Long-Term Survival in 47 PatientsA single-center retrospective study reports durable immune recovery and high long-term survival after hematopoietic stem cell transplantation for a genetic combined immunodeficiency.Nature - BiotechnologyTargeted lipid nanoparticles unlock in vivo human haematopoietic stem cell gene editingDescribes antibody‑modified lipid nanoparticles that deliver genetic edits directly to human haematopoietic stem cells in bone marrow, enabling in vivo modification.PR NewswireDualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBioA news article about a pharmaceutical collaboration that explains the nature of a license-and-development partnership to advance next-generation ADCs and what readers can expect to learn.Longevity TechnologyInsilico revenue surges 287% in H1 2026 driven by major pharma dealsInsilico’s interim results story — a news article looking at a biotech AI company's recent financial jump and deal-driven momentum, useful for investors and industry watchers.